Circular RNA landscape in extracellular vesicles from human biofluids
View abstract on PubMed
Summary
This summary is machine-generated.Extracellular vesicle (EV)-derived circular RNAs (circRNAs) from human biofluids show potential as disease biomarkers. This study identified numerous EV-circRNAs and elucidated RNA-binding protein mechanisms for their sorting into EVs.
Area Of Science
- Biochemistry
- Molecular Biology
- Genomics
Background
- Circular RNAs (circRNAs) are covalently closed, single-stranded RNA molecules with tissue-specific expression.
- Extracellular vesicles (EVs) derived from liquid biopsies are promising sources for biomarker discovery.
- The characteristics and roles of circRNAs within EVs remain largely unexplored.
Purpose Of The Study
- To comprehensively analyze extracellular vesicle-derived circRNAs (EV-circRNAs) across diverse human biofluids.
- To investigate the potential of EV-circRNAs as biomarkers for disease diagnosis and treatment efficacy.
- To elucidate the mechanisms governing the sorting of circRNAs into EVs.
Main Methods
- Transcriptomic analysis of 1082 human biofluid samples (plasma, urine, CSF, bile).
- Validation using RT-qPCR and RNA immunoprecipitation (RIP) assays.
- Computational analysis of EV-circRNA features and RNA-binding protein (RBP) interactions.
Main Results
- Identification of 136,327 unique EV-circRNAs across human biofluids.
- High enrichment of circRNAs with high back-splicing ratios in EVs compared to linear RNAs.
- Discovery of brain-specific and cancer-associated EV-circRNAs, with potential for non-small cell lung cancer (NSCLC) immunotherapy efficacy assessment.
- Identification of YBX1 as a key RBP involved in EV-circRNA sorting.
Conclusions
- This study reveals an extensive repertoire of EV-circRNAs with significant potential as disease biomarkers.
- Elucidation of RBP-mediated sorting mechanisms provides insights into EV-circRNA biogenesis.
- These findings open new avenues for the clinical application of EV-circRNAs in diagnostics and therapeutics.

